Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - tamsulosin hydrochloride 0,4 mg - eq. tamsulosin 0,367 mg; dutasteride 0,5 mg - capsule, hard - 0,5 mg - 0,4 mg - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin and dutasteride

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - tamsulosin hydrochloride - modified release capsules - tamsulosin hydrochloride 0.4 mg - tamsulosin - tamsulosin - treatment of functional symptoms of benign prostatic hyperplasia (bph).

Malta - English - Medicines Authority

rafarm s.a. 12, korinthou str., 15451 neo psihiko, athens, greece - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals

Malta - English - Medicines Authority

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals

Malta - English - Medicines Authority

lavipharm s.a agias marinas str. 19002 peania attica, greece - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals

Kenya - English - Pharmacy and Poisons Board

q pharma dmcc unit no: 2681 dmcc business centre level no. 1 - tamsulosin hcl - capsule - tamsulosin hcl 0.4mg - tamsulosin

Malta - English - Medicines Authority

cipla europe n.v. uitbreidingstraat 80, 2600 antwerp, belgium - dutasteride - soft capsule - dutasteride 0.5 mg - urologicals

United States - English - NLM (National Library of Medicine)

epic pharma, llc - dutasteride (unii: o0j6xjn02i) (dutasteride - unii:o0j6xjn02i) - dutasteride 0.5 mg - dutasteride capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph) in men with an enlarged prostate to: dutasteride capsules in combination with the alpha-adrenergic antagonist, tamsulosin, is indicated for the treatment of symptomatic bph in men with an enlarged prostate. dutasteride capsules are not approved for the prevention of prostate cancer. dutasteride capsules are contraindicated for use in: risk summary dutasteride is contraindicated for use in pregnancy because it may cause harm to the male fetus [see contraindications (4)]. dutasteride is not indicated for use in women. dutasteridem is a 5 alpha-reductase inhibitor that prevents conversion of testosterone to dihydrotestosterone (dht), a hormone necessary for normal development of male genitalia. abnormalities in the genitalia of male fetuses is an expected physiological consequence of inhibition of this conversion. these results are similar to observations in male infants with genetic 5 alpha-reductase deficienc

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - dutasteride; tamsulosin hydrochloride - capsule, hard - 0.5 mg/0.4 milligram(s) - alpha-adrenoreceptor antagonists; tamsulosin and dutasteride

Malta - English - Medicines Authority

doc generici srl via turati, 40-20121, milano, italy - dutasteride - soft capsule - dutasteride 0.5 mg - urologicals